Two Sigma Investments’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Two Sigma Investments’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,060	Closed	-$32K	–	4082
2019 Q3	$32K	Sell	3,060 -7,927	-72%	-$104K	﹤0.01%	3375
2019 Q2	$187K	Sell	10,987 -4,016	-27%	-$109K	﹤0.01%	3107
2019 Q1	$506K	Sell	15,003 -3,545	-19%	-$118K	﹤0.01%	2264
2018 Q4	$542K	Buy	18,548 +17,187	+1,263%	+$762K	﹤0.01%	2051
2018 Q3	$84K	Buy	+1,361	New	+$92.1K	﹤0.01%	3087
2016 Q2	–	Sell	-3,979	Closed	-$372K	–	3328
2016 Q1	$372K	Buy	+3,979	New	+$433K	﹤0.01%	2259

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments's BLCM Position: Q4 2019 in Review

Two Sigma Investments sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2019, closing a stake of 3,060 shares — an estimated $32K sold.

Two Sigma Investments first reported a position in BLCM in Q1 2016 and held it in 6 quarters. The position peaked at $542K in Q4 2018. 51 funds tracked by Wall St. Rank hold BLCM as of Q4 2019.

Two Sigma Investments reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Two Sigma Investments sold 3,060 Bellicum Pharmaceuticals, Inc. shares in Q4 2019, an estimated $32K.
Two Sigma Investments first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2016 and held it in 6 quarters.
Two Sigma Investments's Bellicum Pharmaceuticals, Inc. position peaked at $542K in Q4 2018.
51 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2019.

Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.